197 related articles for article (PubMed ID: 15814634)
21. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
22. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
23. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
24. Altered chemokine receptor expression in papillary thyroid cancer.
González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
[TBL] [Abstract][Full Text] [Related]
25. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
[TBL] [Abstract][Full Text] [Related]
26. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
27. High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis.
Srivastava A; Fuchs B; Zhang K; Ruan M; Halder C; Mahlum E; Weber K; Bolander ME; Sarkar G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4237-43. PubMed ID: 16857797
[TBL] [Abstract][Full Text] [Related]
28. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck.
Zushi Y; Noguchi K; Hashitani S; Sakurai K; Segawa E; Takaoka K; Toyohara Y; Tanaka N; Kishimoto H; Urade M
Int J Oncol; 2008 Dec; 33(6):1133-9. PubMed ID: 19020745
[TBL] [Abstract][Full Text] [Related]
29. The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma.
Wagner PL; Moo TA; Arora N; Liu YF; Zarnegar R; Scognamiglio T; Fahey TJ
Ann Surg Oncol; 2008 Oct; 15(10):2833-41. PubMed ID: 18696160
[TBL] [Abstract][Full Text] [Related]
30. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10?
Kühnelt-Leddihn L; Müller H; Eisendle K; Zelger B; Weinlich G
Arch Dermatol Res; 2012 Apr; 304(3):185-93. PubMed ID: 22350183
[TBL] [Abstract][Full Text] [Related]
32. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma.
Seidl H; Richtig E; Tilz H; Stefan M; Schmidbauer U; Asslaber M; Zatloukal K; Herlyn M; Schaider H
Hum Pathol; 2007 May; 38(5):768-80. PubMed ID: 17306330
[TBL] [Abstract][Full Text] [Related]
33. CDH11 expression is associated with survival in patients with osteosarcoma.
Nakajima G; Patino-Garcia A; Bruheim S; Xi Y; San Julian M; Lecanda F; Sierrasesumaga L; Müller C; Fodstad O; Ju J
Cancer Genomics Proteomics; 2008; 5(1):37-42. PubMed ID: 18359978
[TBL] [Abstract][Full Text] [Related]
34. CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma.
Ishikawa T; Nakashiro K; Hara S; Klosek SK; Li C; Shintani S; Hamakawa H
Int J Oncol; 2006 Jan; 28(1):61-6. PubMed ID: 16327980
[TBL] [Abstract][Full Text] [Related]
35. [Different expressions of chemokine receptors in human hepatocellular carcinoma cell lines with different metastatic potentials].
Xue TC; Chen RX; Ye SL; Sun RX; Chen J; Tang ZY
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):261-5. PubMed ID: 17456312
[TBL] [Abstract][Full Text] [Related]
36. Expression of the chemokine receptor CCR7 in prostate cancer presenting with generalized lymphadenopathy: report of a case, review of the literature, and analysis of chemokine receptor expression.
Heresi GA; Wang J; Taichman R; Chirinos JA; Regalado JJ; Lichtstein DM; Rosenblatt JD
Urol Oncol; 2005; 23(4):261-7. PubMed ID: 16018941
[TBL] [Abstract][Full Text] [Related]
37. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
38. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
[TBL] [Abstract][Full Text] [Related]
39. Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways.
Huang CY; Lee CY; Chen MY; Yang WH; Chen YH; Chang CH; Hsu HC; Fong YC; Tang CH
J Cell Physiol; 2009 Oct; 221(1):204-12. PubMed ID: 19496172
[TBL] [Abstract][Full Text] [Related]
40. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]